Literature DB >> 34324500

Differences in immune status and fecal SCFA between Indonesian stunted children and children with normal nutritional status.

Ingrid S Surono1, Fasli Jalal2, Syukrini Bahri3, Andreas Romulo1, Pratiwi Dyah Kusumo4, Erida Manalu4, Koen Venema5.   

Abstract

We recently showed that the gut microbiota composition of stunted children was different from that of children with normal nutritional status. Here, we compared immune status and fecal microbial metabolite concentrations between stunted and normal children, and we correlated macronutrient intake (including energy), metabolites and immune status to microbiota composition. The results show that macronutrient intake was lower in stunted children for all components, but after correction for multiple comparison significant only for energy and fat. Only TGF-β was significantly different between stunted children and children of normal nutritional status after correction for multiple comparisons. TNF-alpha, IL-10, lipopolysaccharide binding protein in serum and secretory IgA in feces were not significantly different. Strikingly, all the individual short-chain and branched-chain fatty acids were higher in fecal samples of stunted children (significant for acetate, valerate and total SCFA). These metabolites correlated with a number of different microbial taxa, but due to extensive cross-feeding between microbes, did not show a specific pattern. However, the energy-loss due to higher excretion in stunted children of these metabolites, which can be used as substrate for the host, is striking. Several microbial taxa also correlated to the intake of macronutrients (including dietary fibre) and energy. Eisenbergiella positively correlated with all macronutrients, while an uncharacterized genus within the Succinivibrionaceae family negatively correlated with all macronutrients. These, and the other correlations observed, may provide indication on how to modulate the gut microbiota of stunted children such that their growth lag can be corrected. Trail registered at https://clinicaltrials.gov/ct2/show/NCT04698759.

Entities:  

Year:  2021        PMID: 34324500     DOI: 10.1371/journal.pone.0254300

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  Combined Microbiome and Metabolome Analysis Reveals a Novel Interplay Between Intestinal Flora and Serum Metabolites in Lung Cancer.

Authors:  Sai Chen; Rong Gui; Xiong-Hui Zhou; Jun-Hua Zhang; Hai-Ye Jiang; Hai-Ting Liu; Yun-Feng Fu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-02       Impact factor: 6.073

2.  Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal Microbiome and Increasing Intestinal Permeability.

Authors:  Peishi Feng; Qiaoqiao Li; Ling Liu; Siyu Wang; Zhipeng Wu; Yi Tao; Pan Huang; Ping Wang
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.